{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,4]],"date-time":"2026-10-04T01:12:29Z","timestamp":1791076349991,"version":"4.1.0"},"reference-count":29,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2019,3,1]],"date-time":"2019-03-01T00:00:00Z","timestamp":1551398400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["International Journal of Biological Macromolecules"],"published-print":{"date-parts":[[2019,3]]},"DOI":"10.1016\/j.ijbiomac.2018.12.093","type":"journal-article","created":{"date-parts":[[2018,12,10]],"date-time":"2018-12-10T11:54:30Z","timestamp":1544442870000},"page":"785-790","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":31,"special_numbering":"C","title":["A mechanistic investigation on methotrexate-loaded chitosan-based hydrogel nanoparticles intended for CNS drug delivery: Trojan horse effect or not?"],"prefix":"10.1016","volume":"125","author":[{"given":"Leila","family":"Pourtalebi Jahromi","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Fatemeh","family":"Moghaddam Panah","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Amir","family":"Azadi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hajar","family":"Ashrafi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.ijbiomac.2018.12.093_bb0005","doi-asserted-by":"crossref","first-page":"437","DOI":"10.1007\/s10545-013-9608-0","article-title":"Blood\u2013brain barrier structure and function and the challenges for CNS drug delivery","volume":"36","author":"Abbott","year":"2013","journal-title":"J. Inherit. Metab. Dis."},{"key":"10.1016\/j.ijbiomac.2018.12.093_bb0010","doi-asserted-by":"crossref","first-page":"145","DOI":"10.1016\/j.jconrel.2012.04.044","article-title":"Challenges in drug delivery to the brain: nature is against us","volume":"164","author":"Krol","year":"2012","journal-title":"J. Control. Release"},{"key":"10.1016\/j.ijbiomac.2018.12.093_bb0015","doi-asserted-by":"crossref","first-page":"179","DOI":"10.1016\/S0169-409X(98)00085-4","article-title":"P-glycoprotein, a gatekeeper in the blood\u2013brain barrier","volume":"36","author":"Schinkel","year":"1999","journal-title":"Adv. Drug Deliv. Rev."},{"key":"10.1016\/j.ijbiomac.2018.12.093_bb0020","doi-asserted-by":"crossref","first-page":"118","DOI":"10.1177\/153537020523000206","article-title":"Modulation of p-glycoprotein transport function at the blood-brain barrier","volume":"230","author":"Bauer","year":"2005","journal-title":"Exp. Biol. Med."},{"key":"10.1016\/j.ijbiomac.2018.12.093_bb0025","doi-asserted-by":"crossref","first-page":"1638","DOI":"10.1016\/j.addr.2008.08.002","article-title":"Hydrogel nanoparticles in drug delivery","volume":"60","author":"Hamidi","year":"2008","journal-title":"Adv. Drug Deliv. Rev."},{"key":"10.1016\/j.ijbiomac.2018.12.093_bb0030","doi-asserted-by":"crossref","first-page":"1302","DOI":"10.1208\/s12249-011-9695-x","article-title":"Methotrexate-loaded chitosan-and glycolchitosan-based nanoparticles: a promising strategy for the administration of the anticancer drug to brain tumors","volume":"12","author":"Trapani","year":"2011","journal-title":"AAPS PharmSciTech"},{"key":"10.1016\/j.ijbiomac.2018.12.093_bb0035","doi-asserted-by":"crossref","first-page":"523","DOI":"10.1016\/j.ijbiomac.2013.10.004","article-title":"Methotrexate-loaded chitosan nanogels as \u2018Trojan horses\u2019 for drug delivery to brain: preparation and in vitro\/in vivo characterization","volume":"62","author":"Azadi","year":"2013","journal-title":"Int. J. Biol. Macromol."},{"key":"10.1016\/j.ijbiomac.2018.12.093_bb0040","doi-asserted-by":"crossref","first-page":"462","DOI":"10.1016\/j.carbpol.2012.05.066","article-title":"Preparation and optimization of surface-treated methotrexate-loaded nanogels intended for brain delivery","volume":"90","author":"Azadi","year":"2012","journal-title":"Carbohydr. Polym."},{"key":"10.1016\/j.ijbiomac.2018.12.093_bb0045","doi-asserted-by":"crossref","first-page":"326","DOI":"10.1016\/j.ijbiomac.2015.05.001","article-title":"Neuropharmacokinetic evaluation of methotrexate-loaded chitosan nanogels","volume":"79","author":"Azadi","year":"2015","journal-title":"Int. J. Biol. Macromol."},{"key":"10.1016\/j.ijbiomac.2018.12.093_bb0050","doi-asserted-by":"crossref","first-page":"31","DOI":"10.1016\/j.ijbiomac.2015.11.089","article-title":"Chitosan-based hydrogel nanoparticle amazing behaviors during transmission electron microscopy","volume":"84","author":"Ashrafi","year":"2016","journal-title":"Int. J. Biol. Macromol."},{"key":"10.1016\/j.ijbiomac.2018.12.093_bb0055","doi-asserted-by":"crossref","first-page":"305","DOI":"10.18433\/jpps29496","article-title":"In vitro- in vivo evaluation of methotrexate-loaded hydrogel nanoparticles intended to treat primary CNS lymphoma via intranasal administration","volume":"21","author":"Pourtalebi Jahromi","year":"2018","journal-title":"J. Pharm. Pharm. Sci."},{"key":"10.1016\/j.ijbiomac.2018.12.093_bb0060","first-page":"137","article-title":"Treatment of central nervous system tumors with methotrexate","volume":"65","author":"Abelson","year":"1981","journal-title":"Cancer Treat. Rep."},{"key":"10.1016\/j.ijbiomac.2018.12.093_bb0065","doi-asserted-by":"crossref","first-page":"83","DOI":"10.1016\/S0169-409X(02)00172-2","article-title":"Drug efflux transportrs in the CNS","volume":"55","author":"Sun","year":"2003","journal-title":"Adv. Drug Deliv. Rev."},{"key":"10.1016\/j.ijbiomac.2018.12.093_bb0070","doi-asserted-by":"crossref","first-page":"1094","DOI":"10.1056\/NEJM198311033091805","article-title":"The pharmacology and clinical use of methotrexate","volume":"309","author":"Jolivet","year":"1983","journal-title":"N. Engl. J. Med."},{"key":"10.1016\/j.ijbiomac.2018.12.093_bb0075","doi-asserted-by":"crossref","first-page":"1036","DOI":"10.1016\/S1470-2045(10)70229-1","article-title":"High-dose methotrexate with or without whole brain radiotherapy for primary CNS lymphoma (G-PCNSL-SG-1): a phase 3, randomised, non-inferiority trial","volume":"11","author":"Thiel","year":"2010","journal-title":"Lancet Oncol."},{"key":"10.1016\/j.ijbiomac.2018.12.093_bb0080","first-page":"11","article-title":"New approaches in primary central nervous system lymphoma","volume":"4","author":"Fraser","year":"2015","journal-title":"Chin. Clin. Oncol."},{"key":"10.1016\/j.ijbiomac.2018.12.093_bb0085","first-page":"5002","article-title":"Reversal mechanism of multidrug resistance by verapamil: direct binding of verapamil to P-glycoprotein on specific sites and transport of verapamil outward across the plasma membrane of K562\/ADM cells","volume":"49","author":"Yusa","year":"1989","journal-title":"Cancer Res."},{"key":"10.1016\/j.ijbiomac.2018.12.093_bb0090","doi-asserted-by":"crossref","first-page":"47","DOI":"10.1081\/DMR-120001389","article-title":"Drugs as P-glycoprotein substrates, inhibitors, and inducers","volume":"34","author":"Kim","year":"2002","journal-title":"Drug Metab. Rev."},{"key":"10.1016\/j.ijbiomac.2018.12.093_bb0095","first-page":"101","article-title":"Performance liquid chromatography (HPLC) method for bio-analysis of methotrexate","volume":"2","author":"Pourtalebi Jahromi","year":"2016","journal-title":"Trends Pharmacol. Sci."},{"key":"10.1016\/j.ijbiomac.2018.12.093_bb0100","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.ejpb.2007.08.001","article-title":"Nanoparticles for drug delivery: the need for percision in reporting particle size","volume":"69","author":"Gaumet","year":"2008","journal-title":"Eur. J. Pharm. Biopharm."},{"key":"10.1016\/j.ijbiomac.2018.12.093_bb0105","doi-asserted-by":"crossref","first-page":"3518","DOI":"10.1002\/jps.21270","article-title":"Nanovehicular intracellular delivery systems","volume":"97","author":"Prokop","year":"2008","journal-title":"J. Pharm. Sci."},{"key":"10.1016\/j.ijbiomac.2018.12.093_bb0110","doi-asserted-by":"crossref","first-page":"19","DOI":"10.1186\/s12951-015-0075-7","article-title":"The effect of nanoparticle size on the probability to cross the blood-brain barrier: an in-vitro endothelial cell model","volume":"13","author":"Shilo","year":"2015","journal-title":"J. Nanobiotechnol."},{"key":"10.1016\/j.ijbiomac.2018.12.093_bb0115","doi-asserted-by":"crossref","first-page":"1603","DOI":"10.1016\/j.nano.2015.04.015","article-title":"Size, surface charge, and shape determine therapeutic effects of nanoparticles on brain and retinal diseases","volume":"11","author":"Jo","year":"2015","journal-title":"Nanomedicine: NBM"},{"key":"10.1016\/j.ijbiomac.2018.12.093_bb0120","series-title":"InIschemic Blood Flow in the Brain","article-title":"Blood-brain barrier: Role of brain endothelial surface charge and glycocalyx","author":"Johansson","year":"2001"},{"key":"10.1016\/j.ijbiomac.2018.12.093_bb0125","doi-asserted-by":"crossref","first-page":"3","DOI":"10.1016\/j.jconrel.2007.03.022","article-title":"Particle shape: a new design parameter for micro-and nanoscale drug delivery carriers","volume":"121","author":"Champion","year":"2007","journal-title":"J. Control. Release"},{"key":"10.1016\/j.ijbiomac.2018.12.093_bb0130","doi-asserted-by":"crossref","first-page":"10753","DOI":"10.1073\/pnas.1308345110","article-title":"Using shape effects to target antibody-coated nanoparticles to lung and brain endothelium","volume":"110","author":"Kolhar","year":"2013","journal-title":"Proc. Natl. Acad. Sci."},{"key":"10.1016\/j.ijbiomac.2018.12.093_bb0135","first-page":"125","article-title":"Mathematical modeling of drug release from swellable polymeric nanoparticles","volume":"7","author":"Azadi","year":"2017","journal-title":"J. Appl. Pharm. Sci."},{"key":"10.1016\/j.ijbiomac.2018.12.093_bb0140","doi-asserted-by":"crossref","first-page":"3","DOI":"10.1016\/j.addr.2009.09.004","article-title":"Biodegradation, biodistribution and toxicity of chitosan","volume":"62","author":"Kean","year":"2010","journal-title":"Adv. Drug Deliv. Rev."},{"key":"10.1016\/j.ijbiomac.2018.12.093_bb0145","doi-asserted-by":"crossref","first-page":"205","DOI":"10.2165\/00137696-200503030-00004","article-title":"Pharmacoscintigraphic evaluation of polysorbate80-coated chitosan nanoparticles for brain targeting","volume":"3","author":"Soni","year":"2005","journal-title":"Am. J. Drug Deliv."}],"container-title":["International Journal of Biological Macromolecules"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0141813018356496?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0141813018356496?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2019,1,29]],"date-time":"2019-01-29T09:49:27Z","timestamp":1548755367000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0141813018356496"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2019,3]]},"references-count":29,"alternative-id":["S0141813018356496"],"URL":"https:\/\/doi.org\/10.1016\/j.ijbiomac.2018.12.093","relation":{},"ISSN":["0141-8130"],"issn-type":[{"value":"0141-8130","type":"print"}],"subject":[],"published":{"date-parts":[[2019,3]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"A mechanistic investigation on methotrexate-loaded chitosan-based hydrogel nanoparticles intended for CNS drug delivery: Trojan horse effect or not?","name":"articletitle","label":"Article Title"},{"value":"International Journal of Biological Macromolecules","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.ijbiomac.2018.12.093","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2018 Elsevier B.V. All rights reserved.","name":"copyright","label":"Copyright"}]}}